Evaluation of Rocuronium Continuous Infusion in Critically Ill Patients During the COVID-19 Pandemic and Drug Shortages

Evaluation of Rocuronium Continuous Infusion in Critically Ill Patients During the COVID-19 Pandemic and Drug Shortages

Background: Limited data exist to support the use of rocuronium continuous infusions in the intensive care unit (ICU). Objective: To evaluate the dosing and monitoring of adult patients who received rocuronium for hypoxemic respiratory failure during the Coronavirus Disease 2019 (COVID-19) pandemic....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pharmacy practice 2023-04, Vol.36 (2), p.249-255
Hauptverfasser: Aldhaeefi, Mohammed, Dube, Kevin M., Kovacevic, Mary P., Szumita, Paul M., Lupi, Kenneth E., DeGrado, Jeremy R.
Format: Artikel
Sprache:eng
Schlagworte:
Adult
Androstanols
COVID-19
Critical Illness - therapy
Humans
Neuromuscular Nondepolarizing Agents
Pandemics
Retrospective Studies
Rocuronium
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: Limited data exist to support the use of rocuronium continuous infusions in the intensive care unit (ICU). Objective: To evaluate the dosing and monitoring of adult patients who received rocuronium for hypoxemic respiratory failure during the Coronavirus Disease 2019 (COVID-19) pandemic. Methods: This was a retrospective, single-center study from March 1, 2020 to May 31, 2020. We identified all adult patients admitted to any ICU who received rocuronium via continuous infusion. Patients were excluded if they received rocuronium for
ISSN:0897-1900
1531-1937
DOI:10.1177/08971900211033138